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Abstract
Background: Mammalian erythropoiesis can be divided into two distinct types, primitive and definitive, in which
new cells are derived from the yolk sac and hematopoietic stem cells, respectively. Primitive erythropoiesis occurs
within a restricted period during embryogenesis. Primitive erythrocytes remain nucleated, and their hemoglobins
are different from those in definitive erythrocytes. Embryonic type hemoglobin is expressed in adult animals
under genetically abnormal condition, but its later expression has not been reported in genetically normal adult
animals, even under anemic conditions. We previously reported that injecting animals with nitrogen-containing
bisphosphonate (NBP) decreased erythropoiesis in bone marrow (BM). Here, we induced severe anemia in a
mouse model by injecting NBP injection in combination with phenylhydrazine (PHZ), and then we analyzed
erythropoiesis and the levels of different types of hemoglobin.
Methods: Splenectomized mice were treated with NBP to inhibit erythropoiesis in BM, and with PHZ to induce
hemolytic anemia. We analyzed hematopoietic sites and peripheral blood using morphological and molecular
biological methods.
Results: Combined treatment of splenectomized mice with NBP and PHZ induced critical anemia compared to
treatment with PHZ alone, and numerous nucleated erythrocytes appeared in the peripheral blood. In the BM,
immature CD71-positive erythroblasts were increased, and extramedullary erythropoiesis occurred in the liver.
Furthermore, embryonic type globin mRNA was detected in both the BM and the liver. In peripheral blood, spots
that did not correspond to control hemoglobin were observed in 2D electrophoresis. ChIP analyses showed that
KLF1 and KLF2 bind to the promoter regions of β-like globin. Wine-colored capsuled structures were unexpectedly
observed in the abdominal cavity, and active erythropoiesis was also observed in these structures.
Conclusion: These results indicate that primitive erythropoiesis occurs in adult mice to rescue critical anemia because
primitive erythropoiesis does not require macrophages as stroma whereas macrophages play a pivotal role in definitive
erythropoiesis even outside the medulla. The cells expressing embryonic hemoglobin in this study were similar
to primitive erythrocytes, indicating the possibility that yolk sac-derived primitive erythroid cells may persist into
adulthood in mice.
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Mammalian hematopoiesis occurs in two distinct waves,
commonly referred to as primitive and definitive, that
originate in the yolk sac and in the fetal liver and bone
marrow (BM), respectively [1]. Yolk sac-derived primitive
erythroid cells remain nucleated and enucleated terminally
in the circulation, whereas definitive erythroid cells pro-
duced in the fetal liver are released into circulation after
complete maturation [2–5]. The components of the globin
tetramer are encoded by the α- and β-globin gene loci.
There are 3 functional α-globins (ζ-, α1- and α2) and 4 β-
globins (Ey-, βh1-, β1- and β2-) in mice [2, 6, 7]. Primitive
erythrocytes express the embryonic complement of globin
chains, which initially consist of ζ- and βh1-globins,
followed by α1- and α2-, and Ey-globins at the primi-
tive proerythroblast stage [2, 6, 7]. Definitive erythroid
cells complete their maturation and enucleation at
erythropoietic sites, the fetal liver and BM, where the
adult complement of globin chains consists of α1-, α2- β1-
and β2- are expressed. All of the globin genes in the α-
and β-globin clusters are expressed in primitive erythroid
cells, whereas definitive erythroid cells express only the
adult globin genes [8].
The expression of globin genes is jointly regulated by
elements in the promoter regions and an upstream en-
hancer region called, the locus control region (LCR) [5].
The TATA, CAAT and CACCC regulatory elements are
found within the promoters of all globin genes. A variety
of nuclear factors that are involved in transcriptional
regulation have been suggested to be related to globin
gene expression and switches between them [9, 10].
Members of the KLF (Kruppel-like factor) family are
known as an essential transcription factor that bind
GC-rich sequences, such as the CACCC element, to
regulate the biological dynamic during development
[11]. KLF1 (EKLF: erythroid Kruppel-like factor) is a
member of the KLF family that plays an essential role
in erythropoiesis and is involved in the expression of β-
like embryonic globin by binding to its promoter region
[12, 13]. KLF2 has been found to regulate biological ac-
tivity in various tissues and to enhance the expression
of β-like embryonic globin [14, 15].
All hematopoietic cells are derived from hematopoietic
stem cells (HSC) that develop into mature lineage cells
during definitive hematopoiesis [2, 5]. Definitive erythropoi-
esis requires a specific microenvironment that contacts
stromal cells; these groups of cells are called “erythroblastic
islands”. Macrophages directly contact erythroid progeni-
tors in the BM and fetal liver via several types of adhesion
molecules, including EMP, αV integrin and VCAM-1, which
participate in their differentiation, survival and maturation
during erythropoiesis [16–19]. These central macrophages
may also be an important source of cytokines, particularly
erythropoietin (EPO), which supports the maturation oferythroid cells [20, 21]. However, primitive erythropoiesis
occurs without macrophages and some cytokines, such
as SCF and EPO, are essential for definitive erythropoiesis
[3]. These results indicate that erythroblast-macrophage
interactions might be specifically essential for definitive
erythropoiesis.
Bisphosphonates (BPs) are potent inhibitors of osteoclast-
mediated bone resorption and are used as therapeutic
agents against bone resorptive disorders such as osteo-
porosis and metastatic bone diseases [22, 23]. The use
of nitrogen-containing bisphosphonates (NBPs) results
in strong anti-bone resorptive effects that are much
more potent than the effect of non-nitrogen-containing
bisphosphonates (non-NBPs). In addition, NBPs have
inflammatory side effects including fever, jaw osteomyelitis,
osteonecrosis and extramedullary erythropoiesis [24–26].
Our previous study reported that a single injection of a
relatively large dose of the NBP into mice inhibited
bone resorption by osteoclasts, induced extramedullary
erythropoiesis by depleting resident BM macrophages
and increased the number of granulocytes in the peripheral
blood [26]. Moreover, the injection of an NBP into splenec-
tomized mice induced extramedullary erythropoiesis with-
out anemia and alterations in EPO concentrations in the
liver [27]. Phenylhydrazine (PHZ) is used to experimentally
induce hemolytic anemia in laboratory animals [28].
The mechanism by which it causes anemia is RBC lipid
peroxidation [29]. These results lead to suggest the change
of erythropoiesis in the medullary and extramedullary
hematopoietic sites by treatment with both NBP and PHZ,
which indirectly inhibits erythropoiesis and directly
disrupts erythrocytes.
In this study, we established a model of critical anemia
in mice through the combined use of NBP with PHZ and
analyzed the expression pattern of hemoglobin as well as
changes in erythropoiesis and erythropoiesis-regulated fac-
tors in medullary and extramedullary erythropoietic sites.
Methods
Animals
Sixty female BALB/c mice (6-week-old) were obtained
from Sankyo Laboratories (Tokyo, Japan), and were fed
under specific pathogen-free conditions. The mice were
anesthetized with an intraperitoneal injection of sodium
pentobarbital (50 mg/kg) and performed splenectomies
as described in previous reports [27]. The mice were
divided into 5 group: a non-treatment group (5 mice),
a splenectomized control group (20 mice), a splenecto-
mized and NBP treatment group (10 mice), a splenecto-
mized and PHZ treatment group (5 mice), and a
splenectomized and both NBP and PHZ treatment
group (20 mice). NBP (40 μmol/kg) or sterile saline was
intraperitoneally injected into splenectomized mice 7 days
after splenectomy. Two days after NBP injection, the mice
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killed 3 days after the PHZ or saline treatment (Fig. 1a).
The NBP used in this study was 4-amino-1-hydroxybutyli-
dene-1, 1-bisphosphonate (AHBuBP), which was prepared
as previously described [24, 26, 27].
All experimental protocols used in this study were
reviewed and approved by the Animal Care Committee
of Showa University (Permit Number: 14043).
Blood analyses
Peripheral blood samples were collected and centrifuged
(10000 × g) to determine hematocrit values, and serum
was then separated using centrifugation (1000 × g). To
obtain serum EPO measurements, we used an EPO
Mouse ELISA Kit (R & D systems, Minneapolis, MN,
USA) according manufacturer’s protocol, and whole
blood was prepared in blood smears and performed the
May-Grünwald Giemsa staining technique.
Antibodies and other materials
The monoclonal antibodies used in this study were as
follows: purified anti-mouse TER-119 and anti-mouse
CD71, FITC-conjugated anti-mouse TER-119 and PE-
conjugated anti-mouse CD71 antibodies were purchased
from BD Pharmingen (San Diego, CA, USA). Normal
rabbit IgG, biotinylated goat anti-rat IgG antibodies andFig. 1 Experimental schedule and the analysis of peripheral blood. a The s
every day (gray arrowhead), and tissue samples were obtained at 5 days af
treatment (control, NBP alone, PHZ alone or NBP + PHZ). b The hematocrit
observed by treatment with NBP alone, significant reduction were observe
animals treated with both NBP and PHZ (NBP + PHZ). c The hematocrit valu
PHZ (NBP + PHZ). Treatment with PHZ and NBP resulted in a significant red
after the NBP injection was detected. d The EPO concentration in the serum
EPO concentrations compared to the control. The error bars indicate the stan avidin-biotin complex kit (ABC Elite standard kit)
were purchased from Vector Laboratories (Burlingame,
CA, USA). The polyclonal antibodies for ChIP, anti-KLF1
and KLF2 assays were obtained from Abcam (Cambridge,
UK), and an alkaline-phosphatase (AP)-conjugated
anti-digoxygenin (DIG) antibody was purchased from
Roche (Basel, Switzerland). Anti-mouse TER119 anti-
body microbeads were purchased from Miltenyi Biotec
(Bergisch Gladbach, DE).
Tissue preparation
The tissue samples were fixed in 4 % paraformaldehyde
prepared in phosphate-buffered saline (PBS). Tibias were
demineralized using 10 % ethylenediaminetetraacetic acid
(EDTA). Demineralized tibia and soft tissues were washed
in 20 % sucrose-PBS, embedded in O.C.T. compound
(Sakura Finetek Japan, Tokyo, Japan), and quickly frozen
in a mixture of acetone and dry ice. Frozen sections (8 μm
thick) were cut, placed on SILANE-coated glass slides,
and air dried.
Flow cytometry
The cells isolated from BM, the liver and peripheral
blood were obtained as previously described [27, 30],
washed using FACS solution (1 mM EDTA, 0.2 % BSA
and 0.1 % NaN3 in PBS), and incubated with FITC-chema of the experimental schedule. Blood sample were collected
ter NBP injection (white arrowhead). Arrows indicate the time of the
values of all groups at 5 days after treatment. No change was
d by PHZ treatment. Moreover, serious anemia was induced in the
es in the control animals and the animals treated with both NBP and
uction in hematocrit values after PHZ injection, which occurred 3 days
. The PHZ and NBP group (PHZ + NBP) had significantly increased
andard error of the mean (SEM)
Table 1 Used primer sequence
Name Sequence Annealing(°C)
Product size
Actin F: 5’-GCGTGACATTAAAGAGAAGCTG-3’ 60
R: 5’-CTCAGGAGGAGCAATGATCTTG-3 376 bp
Hba F: 5’-CTCTCTGGGGAAGACAAAAGCAAC-3’ 55
R: 5’-GGTGGCTAGCCAAGGTCACCAGCA-3’ 334 bp
Hbb1 F: 5’-CACAAACCCCAGAAACAGACA-3’ 55
R: 5’-CTGACAGATGCTCTCTTGGG-3’ 529 bp
Hba-x F: 5’- CTGTCTGCTGGTCACAATGG -3’ 55
R: 5’- GGGAGGAGAGGGATCATAGC -3’ 165 bp
Hbb-bh1 F: 5’-TGGACAACCTCAAGGAGACC-3’ 55
R: 5’- TGCCAGTGTACTGGAATGGA -3’ 231 bp
Hbb-y F: 5’-CTTGGGTAATGTGCTGGTGA-3’ 55
R: 5’-GTGCAGAAAGGAGGCATAGC-3 183 bp
Klf1 F: 5’-CCTCCATCAGTACACTCACC-3’ 55
R: 5’-CCTCCGATT TCAGACTCACG-3’ 150 bp
Klf2 F: 5’-CCAAGAGCTCGCACCTAAAG-3’ 55
R: 5’-GTGGCACTGAAAGGGTCTGT-3’ 155 bp
Bcl11a F: 5’-AACCCCAGCACTTAAGCAAA-3’ 55
R: 5’-ACAGGTGAGAAGGTCGTGGT-3’ 122 bp
Gata1 F: 5’- ACCACTACAACACTCTGGCG -3’ 60








R: 5’-GGGTTTTTTCCTCAGCAGTAAAGT-3’ 79 bp
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antibodies or rat IgG (isotype control) in 1%BSA in PBS.
After washing, the cells, they were resuspended in FACS
solution and analyzed using a FACS Verse flow cyt-
ometer (BD Bioscience, Rockville, MD, USA). The data
were collected for 10,000 events, stored in list mode,
and subsequently analyzed using the BD FACS Suite
software (BD Bioscience, Rockville, MD, USA).
Histology and immunohistochemistry
Some sections were stained with hematoxylin-eosin
(HE). The remaining sections were rinsed in PBS and
fixed in 0.3 % H2O2-methanol for 30 min. After several
PBS washes, the sections were incubated in 5 % normal
goat serum in PBS. These sections were then incubated
with an anti-TER119 or anti-CD71 antibody (1:50). After
several rinses with PBS, the sections were incubated with
biotinylated goat anti-rat antibodies, followed by a solu-
tion containing avidin-biotin-horseradish peroxidase
complex. After the sections were washed, they incubated
with a mixture of a DAB detection kit (KPL, Gaithersburg,
MD, USA). Hematoxylin was used for counterstaining.
In situ hybridization (ISH)
ISH was performed as previously described [31]. Antisense
probes were designed to detect murine hba-x (ζ-globin,
accession no. NM_010405), hbb-bh1 (βh1-globin, acces-
sion no. NM_489729) and hbb-y (Ey-globin, accession no.
NM_008219). All accession numbers were obtained from
the Entrez nucleotide database. The designed probes were
labeled using digoxygenin (RNA DIG labeling kit; Roche,
Basel, Switzerland). The samples were fixed with 4 % para-
formaldehyde and 0.5 % glutaraldehyde and prepared as
frozen sections. The frozen sections were washed with
PBS, digested with 1 μg/ml Proteinase K, and hybridized
in separate buffer solution (50 % deionized formamide,
2 × SSC, 10 % dextran sulfate, and 0.01 % sheared yeast
tRNA) containing each probe at 1 μg/ml at 50 °C. After
hybridization, the sections were washed in SSC and
unreacted probes were ablated using RNase A (Wako,
Osaka, Japan). The probes were visualized using an AP-
conjugated anti-DIG antibody with NBT/BCIP used as
the substrate (Roche, Basel, Switzerland).
RT-PCR, chromatin immune precipitation and quantitative
RT-PCR
Mononuclear cells were isolated from BM and the liver
as previously described [27], and TER119-positive cells
were collected using the MidiMACS system immuno-
magnetic separation method, (Miltenyi Biotec, Bergisch
Gladbach, DE). Total RNA was isolated using an RNeasy
Mini kit (QIAGEN K.K., Hilden, DE) and reverse tran-
scribed into cDNA using a PrimeScript RT reagent Kit
(Takara, Shiga, Japan). A chromatin immune precipitation(ChIP) was performed according to the manufacturer’s
instructions (Ez-ChIP; Millipore, Billerica, MA, US). PCR
analysis was performed using Takara ExTaq® (Takara,
Shiga, Japan). The primer sequences and annealing tem-
peratures used in PCR are listed in Table 1.
Quantitative RT-PCR (qRT-PCR) was performed using
an Applied Biosystems7500 Fast Real-time PCR system
(Applied Biosystems Inc., Foster City, CA, USA) The fol-
lowing program was used: 50 cycles at 95 °C for 3 sec and
60 °C for 30 sec. The expression of different globin genes
was measured using control ct values, and the ct values ob-
tained for actin expression were used for normalization.
The primers and probes used for qRT-PCR (TaqMan® gene
expression assay, assay ID: Hba, Mm00845395_s1, Hbb1,
Mm01611268_g1, Hba-x, Mm00439255_m1, Hbb-bh1,
Mm00433932_g1 and Hbb-y, Mm00433936_g1) were ob-
tained from Applied Biosystems (Foster City, CA, USA).
2D electrophoresis
Hemoglobin was isolated from blood samples, and 2D
electrophoresis was performed as previously described
[32]. The samples obtained from the hemolytic blood
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Tokyo, Japan). The carrier ampholyte isoelectric fo-
cusing method was combined with 10 % SDS-PAGE
according to instructions in the ATTO Technical
Manual (http://www.atto.co.jp/kotsu_series.html), and
the gels were then stained using silver. The gel images
were observed using chemiDoc (Bio-Rad, Hercules, CA,
USA) and analyzed using NIH image software.
Statistical analysis
For quantitative data analysis, a t-test was used to de-
termine differences between paired samples. A p-value
of <0.05 was considered statistically significant.
Results
Blood analyses
We collected peripheral blood to evaluate hematocrit
value, to measure the serum EPO concentrations and to
observe erythrocytes in blood smears. No changes were
observed in hematocrit values and serum EPO levels in
animals treated with splenectomy and NBP alone com-
pared to the values in the non-treatment group (Fig. 1b).
In splenectomized mice treated with PHZ, a significant
reduction in hematocrit values was observed compared
to controls and to animals treated with NBP alone
(Fig. 1b). However, treating animals with both NBP and
PHZ (NBP + PHZ) induced more serious anemia thanFig. 2 Morphological analysis of peripheral blood. a Blood smears stained
treated with NBP-alone (at 5 days after the NBP) and both NBP and PHZ (a
the NBP + PHZ mice (arrows). b Flow cytometry analysis of erythroid lineage c
of cells in the control and NBP-alone groups were single-positive TER119 cells
double-positive cells was significantly increased by treatment with NBP and P
detection of CD71-positive cells in peripheral blood of splenectomized mice t
were observed (arrows in left panel), and CD71-positive nucleated cells also
statistical significance, and NS denote no significance versus the control. Barsadministering PHZ alone (Fig. 1b). In an analysis of
time-dependent changes following NBP injection, the
hematocrit values in animals treated with both NBP and
PHZ (NBP + PHZ) were significantly reduced compared
to control animals at 1-3 days after PHZ-treatment
(Fig. 1c). The concentration of EPO in serum samples
taken from mice treated with NBP and PHZ was also
significantly increased at 1-3days after PHZ-treatment
(Fig. 1d).
The blood smears showed that only normal enucleated
erythrocytes were observed in the control and NBP-only
groups (Fig. 2a). In contrast, numerous nucleated eryth-
rocytes and reticulocytes were observed in the peripheral
blood of mice treated with both NBP and PHZ (Fig. 2a).
Flow cytometric analysis showed that the number of
TER119 and CD71 double-positive cells was markedly
increased in the mice treated with both NBP and PHZ,
while almost erythrocytes were single-positive for TER119
in the other groups (Fig. 2b). In the blood vessel, some
CD71-positive nucleated erythroid cells were observed in
addition to CD71-positive reticulocytes (Fig. 2c).
These results indicate that splenectomized mice treated
with both NBP and PHZ become critically anemic and
display a significant increase in EPO levels, which en-
hances erythropoiesis. The results from the blood smears
suggest the induction of abnormal erythropoiesis because
nucleated erythrocytes are not normally observed inwith May-Grünwald Giemsa stain in control animals and the animals
t 3 days after PHZ). Nucleated erythroid cells were easily detected in
ells in the peripheral blood at 5 days after NBP injection. The majority
at 5 days after NBP injection, whereas the number of TER119 and CD71
HZ (NBP + PHZ) at 3 days after PHZ injection. c Immunohistochemical
reated with NBP and PHZ (3 days after PHZ). CD71-positive reticulocytes
existed in the blood vessel (arrows in right panel). Asterisks indicate
indicate 10 μm (a) and 25 μm (c). The error bars indicate the SEM
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Detection of erythropoiesis in the BM
In the control BM samples, appropriately 20 % of all
BM cells were TER119-positive, and three-fourth of the
TER119-positive population of cells was TER119/CD71
double-positive (Fig. 3a). The TER119-positive erythroid
lineage was significantly decreased by the injection of NBP
(NBP alone) as a result of the elimination of resident BM
macrophages, as previously described [26, 27]. However,
the proportion of TER119-/CD71- double-positive cells in
the NBP and PHZ group (NBP + PHZ) was significantly
increased despite the use of NBP (Fig. 3a). The enhancedFig. 3 Erythropoiesis in the BM and liver. a Flow cytometric analysis of eryt
animals, TER119 single-positive and TER119 and CD71 double-positive eryth
decrease in the number of TER119-positive cells was induced by the NBP in
the number of TER119 and CD71 double-positive (erythroid lineage) cells w
analysis of erythroid cells in the liver at 5 days after the treatment. The num
with both NBP and PHZ. TER119 and CD71 double-positive cells were rare
number of TER119/CD71-double-positive erythroblasts was decreased with
erythroblasts was higher in the group treated with both NBP and PHZ. c Im
5 days after the treatment. TER119-positive cells were significantly decrease
detected in the group treated with both NBP and PHZ (NBP + PHZ). d Hist
5 days after NBP injection. The left panel shows HE staining. Mononuclear
The middle and right panel show immunohistochemistry for TER119 and CD
TER119- and CD71-positive erythroblasts (arrow). Bars indicated 50 μm (c) andgranulopoiesis and relative reduction of B-lymphopoiesis
were observed in the BM of the animals treated with both
NBP and PHZ (Additional file 1).
Many of the TER119-positive cells formed clusters in
the control mice, as shown by immunohistochemistry
(Fig. 3c). In the NBP-treated mice (NBP alone), fewer
TER119-positive cells appeared to form into clusters in
the BM (Fig. 3c). However, more TER119-positive cells
were detected in the BM of the mice treated with both
NBP and PHZ (Fig. 3c).
These results suggest that elevated levels of EPO
supports the maturation of the erythroid lineage in the
absence of BM macrophages and inhibits apoptosis
during erythropoiesis in BM.hroid cells in the BM at 5 days after the treatment. In the controls
roid lineage cells comprised the majority of the cells. A significant
jection. In the animals treated with both NBP and PHZ (NBP + PHZ),
as markedly increased despite treated with NBP. b Flow cytometric
ber of TER119 single-positive cells was decreased in animals treated
in the control animals but were increased by treatment with NBP. The
the NBP treatment. The number of TER119/CD71 double-positive
munohistochemical detection of TER119-positive cells in the BM at
d by NBP treatment alone, but a decline in erythropoiesis was not
ological analysis of the livers of mice treated with NBP and PHZ at
cells accumulated in the liver and formed numerous clusters (arrow).
71, respectively. The cells that formed clusters in the liver were
25 μm (d). The error bars indicate the SEM (a and b)
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In splenectomized mice, the liver is the main site of
extramedullary erythropoiesis. Therefore, we next eval-
uated hepatic erythropoiesis using histological and im-
munohistochemical methods and flow cytometry. In
control mice, TER119 single-positive cells were the most
abundant, and CD71 double-positive cells were very rare
(Fig. 3b). After the injection of NBP alone, the number of
TER119 and CD71 double-positive cells was slightly in-
creased (Fig. 3b). These results indicate that extramedul-
lary erythropoiesis was induced in the liver. Furthermore,
treatment with both NBP and PHZ induced a significant
increase in TER119 and CD71 double-positive cells in the
liver (Fig. 3b).
Histological analysis indicated the clusters of mono-
nuclear cells in the livers of splenectomized mice treated
with PHZ and NBP (Fig. 3d). These cells were TER119-
positive and/or CD71-positive erythroblasts (Fig. 3d).
Immunohistochmically, the clusters of granulocytes and
lymphocytes could not be detected in the liver.
The injection of NBP and PHZ therefore induced
extramedullary erythropoiesis in the liver and signifi-
cantly increased the formation of erythroblast clusters
compared to results in the control and NBP-only groups.
Expression of embryonic globin mRNAs at hematopoietic
sites
To determine the expression pattern of hemoglobin sub-
units, we performed RT-PCR analysis on TER119-positive
hematopoietic cells isolated from BM and the liver and col-
lected using MACS (Miltenyi Biotec, Bergisch Gladbach,Fig. 4 Expression of embryonic globins in the BM and liver. a RT-PCR analy
globins were expressed in the BM. Embryonic globins (Hba-x: ζ-, Hbb-bha1:
NBP and PHZ (NBP + PHZ) in the BM and liver. b In situ hybridization to detec
cells that formed clusters in the liver expressed embryonic globins. These cells
peripheral blood. The control showed three spots approximately 16 kDa in siz
splenectomized mice that were treated with both NBP and PHZ (NBP + PHZ),DE). The embryonic globins ζ-, βh1- and Ey- (Hba-x, Hbb-
bh1 and Hbb-y) and the adult globins α- and β major (Hba
and Hbb1) were expressed in BM and the liver in the PHZ-
and NBP-treated mice, whereas the TER119-positive cells
in the control mice expressed only the adult globins
(Fig. 4a). The expression level of embryonic globins in the
liver was higher than the level in the BM, and Hbb-y was
not detected in the control mice (Additional file 2). These
results suggest that abnormal erythropoiesis may occur in
this critical anemic model and that embryonic globins may
be activated as a response to hypoxemia.
We next performed in situ hybridization to identify
the cell clusters that expressed the embryonic globins ζ-,
βh1- and Ey- (Hba-x, Hbb-bh1 and Hbb-y) in the BM
and liver of mice treated with both NBP and PHZ. We
observed the expression of embryonic globins in the BM
(Fig. 4b), but only a small number of cells expressed
embryonic globin in the BM.
These results show that both embryonic-type and
adult-type hemoglobin are co-expressed in clusters of
cells in the BM and livers in splenectomized mice that
were treated with NBP and PHZ and that definitive
erythropoiesis could be of primary importance in the
BM under these conditions.
Hemoglobin fraction in the peripheral blood
We performed qRT-PCR to detect embryonic globins in
the peripheral blood but did not detect the globins of
embryonic-type in the control mice (Additional file 3).
Therefore, we analyzed the pattern of hemoglobin ex-
pression in peripheral blood using 2D electrophoresis.sis of globin mRNAs in the BM and liver. In control animals, only adult
βh1- and Hbb-y: Ey-globin) were expressed after treatment with both
t embryonic globin. Some of hematopoietic cells in the BM and some
were diffuse in the BM. Bars indicate 20 μm. c 2D electrophoresis in the
e. Three additional spots (arrows) appeared in the analysis of the blood of
with represented ζ-, βh1- and Ey-embryonic globin
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globins are very similar, the isoelectric points of embryonic
globins differ from those of adult globins (Additional file
4). Control erythrocytes showed only 3 adult globin spots:
α (α1 and α2 are the same), β major and β minor (Fig. 4c).
The molecular weight of these globins were approximately
15.5-16.5 kDa, and the isoelectric points were different
(Fig. 4c). However, erythrocytes from the NBP- and PHZ-
treated mice showed 6 spots corresponding to 3 definitive
globins and 3 embryonic globins (Fig. 4c).
These results indicate that embryonic globins were
induced at both the mRNA and protein levels by treat-
ment with both NBP and PHZ and that these globins
can form embryonic or semi-embryonic type hemoglobin
subunits.Expression of embryonic globin transcription factors
The expression of several embryonic globin transcription
factors was analyzed using RT-PCR. The expression
levels of Klf1, Klf2 and Gata1 were up-regulated, but the
level of Bcl11a was unchanged in control animals and
animals treated with NBP and PHZ (NBP + PHZ) (Fig. 5a).
Because the expression of Klf1 and Klf2 was markedly
increased, we used ChIP and PCR (ChIP-PCR) targeting
of the embryonic globin promoters with anti-KLF1 or
anti-KLF2 antibodies. DNA fragments that bound to KLF1
or KLF2 were used for globin promoter PCR. The results
showed that binding of the βh1- and Ey-globin promoters
bound KLF1 and KLF2 in the BM and livers of mice
treated with NBP and PHZ (Fig. 5b). These results indicate
that KLF1 and/or KLF2 regulate the transcription of em-
bryonic β-like globins in the BM and liver. The expression
patterns of Bcl11a suggests that the globin switching
mechanism observed in this study might be different
from the mechanism used during embryogenesis because
Bcl11a plays an essential role in globin switching in nor-
mal ontogenic development of eythropoiesis.Fig. 5 The expression of erythropoiesis-related transcription factors in the B
(Gata1, Klf1 and Klf2) were up-regulated in the BM and liver after treatment
the expression of Bcl11a. b ChIP-PCR analysis of KLF1 and KLF2 promoter-b
using PCR amplification in splenectomized mice that were treated with NB
as a positive control. NC indicates results of PCR performed without primerExtramedullary erythropoiesis in newly identified
structures
Extramedullary erythropoiesis occurs in various organs,
including the lungs, heart, thymus, and hemal nodes,
under abnormal conditions.
In this study, we unexpectedly observed the formations
of wine-colored miliary structures in the abdominal
cavities of several mice that were treated with both
NBP and PHZ (Fig. 6a). In histological examination,
these structures were capsule-shaped and filled with
many hematopoietic cells, including megakaryocytes
(Fig. 6b). Immunohistochemical analysis showed that
many of the mononucleated cells were TER119-positive
erythroblasts (Fig. 6c). Moreover, the embryonic globin
mRNA was detected in these structure (Fig. 6d). These
results indicated that these structures were the site of
induction for extramedullary erythropoiesis in this crit-
ically anemic mouse model.
Discussion
Primitive and definitive erythroid cells display many
differences that are consistent with the notion that they
constitute distinct erythroid lineages. The two sequences
of erythropoietic events that lead to the development of
these cells never occur simultaneously in adults; therefore,
embryonic globin is not expressed in adult mammals
under normal conditions [2, 5, 9, 31]. However, in this
study, we detected the expression of embryonic globins in
genetically normal adult splenectomized mice under spe-
cific conditions including the the elimination of BM resi-
dent macrophages and the induction of critical anemia.
Moreover, numerous nucleated erythrocytes appeared in
the peripheral blood, and some erythroid cells were found
to be CD71-positive. These cells were very similar to
primitive erythrocytes [32]. Although certain diseases such
as thalassemia and some knockout models that contain
deletions in some important hemoglobin switching genes
are associated with the expression of embryonic globinsM and liver. a The expression levels of erythropoiesis-related factors
with both NBP and PHZ (NBP + PHZ), but no change was observed in
inding region. KLF1 and KLF2 promoter-binding regions were detected
P and PHZ but not in control animals. Genomic DNA (gDNA) was used
s. Rabbit IgG was used as a negative control for ChIP
Fig. 6 Extramedullary erythropoiesis in newly identified structures. a Macroscopic observation of the abdominal cavity. Wine-colored structures
were observed in the omentum in splenectomized mice that were treated with both NBP and PHZ (arrow). b The histological analysis stained
with H-E. Numerous hematopoietic cells including megakaryocytes (arrow), were observed in these structures. c Immunohistochemical detection
of TER119-positive cells. Most of the cells in this structure were TER119-positive erythroblasts. d RT-PCR analysis to determine globin mRNA levels
in these newly identified structures. Both adult and embryonic globin mRNAs were expressed. Bars show 25 μm (b, c)
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adult mice express embryonic globins [32–34]. Therefore,
the present study contributes a novel experimental model
that can be used to analyze the expression of embryonic
globins and the results of this study suggests that yolk sac-
derived primitive erythroid precursors are maintained in
adult mammals in this model.
Various transcription factors related to erythropoiesis
and the regulation of hemoglobin expression have been
identified [5, 11]. In this study, the up-regulation of Klf1
and Klf2 was detected in the BM and liver. Moreover,
we also confirmed KLF1 and KLF binding to the pro-
moter region of β-like embryonic globin. These results
indicate that KLF1 and KLF2 regulate the expression of
β-like embryonic globin. We detected the expression of
Gata1 and Bcl11a mRNAs in the BM and liver in sple-
nectomized mice that were treated with both NBP and
PHZ. A recent study has shown that Bcl11a expression
is regulated by KLF1, suggesting an intricate mechanism
in which the developmental regulation of β-like globin
genes is coordinated by KLF1 and Bcl11a [35]. In fact,
the conditional knock out of Bcl11a in mice resulted in
a decrease in the expression levels of embryonic globins
in the BM compared to levels in the E18.5 fetal liver
[36]. In this study, Bcl11a was constitutively expressed
in the BM and liver under normal conditions, and its ex-
pression levels were unchanged even in animals with
anemia. These results suggest that Bcl11a may not beassociated with the expression of embryonic globin in
this study because the cells expressing embryonic globin
contained decreased levels of Bcl11a and the cells that
expressed adult globin showed no change in the expres-
sion of Bcl11a. In addition, Bcl11a is essential for normal
lymphocyte development mice.
During embryogenesis, the embryo is exposed to hyp-
oxemia. Therefore, primitive hemoglobin has a higher
affinity for oxygen than adult hemoglobin because it
must provide all oxygenation to the body, and changes
in the partial pressure of oxygen has been associated
with globin switching [37, 38]. Our data suggest that
the expression of embryonic globins might be more ef-
fectively rescuing the hypoxemia that is associated with
critical anemia than the enhanced production of normal de-
finitive erythroid cells. The hypoxic response is controlled
by two transcriptional regulatory complexes called hypoxia
inducible factors (HIFs). These link iron homeostasis and
erythropoiesis by targeting EPO [5, 39]. Although a direct
association between the HIFs and the expression of embry-
onic globins has not been described, EPO has been sug-
gested to support primitive hematopoiesis and to increase
the expression of embryonic globin during embryogenesis
[40, 41]. Therefore, the high EPO concentration caused by
hypoxia might be partially responsible for the expression of
embryonic globins in this study.
We confirmed that there were differences in expression
patterns between the BM and liver, suggesting that cells in
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different mechanism and/or from a cell origin that is dif-
ferent from that in the BM. In fact, some hematopoiesis-
related factors show different expression patterns between
the E18.5 fetal BM and liver [42]. Our ISH data indicate
that a relatively large number of cells expressed embryonic
globins in the liver whereas only a few cells expressed
these mRNAs in the BM. qRT-PCR analysis also showed
that the expression level of embryonic globin in the liver
was higher than level in the BM (Additional file 2).
Erythropoiesis in the BM may primarily produce definitive
erythroid cells, and the primitive-type may originate from
a small population of hematopoietic cells. The liver is
associated with fetal hematopoiesis, including primitive
erythropoiesis [43]. These results may be related to
the availability for quick induction of extramedullary
hematopoiesis and the formation of a niche for primitive
erythropoiesis in the liver.
Resident macrophages act as pivotal stromal cells during
definitive erythropoiesis. In fact, erythropoiesis was inhib-
ited by the elimination of BM resident macrophages in
our previous studies [26, 27]. In addition, macrophages
perform essential roles even in extramedullary erythropoi-
esis and abnormal erythropoiesis, such as that observed in
β-thalassemia, whereas primitive erythroid cells do not re-
quire macrophages in the stroma [44]. An ISH study indi-
cated that some TER119-positive colonies were composed
of both embryonic globin-expressing and -non-expressing
cells. In the early stage of the transition from primitive to
definitive hematopoiesis, primitive hematopoietic cells mi-
grate to the fetal liver, contact macrophages, and continue
to express embryonic type globins within a short period of
time. In our experiments, some of the TER119-positive
cells did not express embryonic globin mRNAs. These
results did not clearly indicate the origin of the
hematopoietic cells expressing embryonic globins, but
they do suggest that the expression of embryonic globins
in this study could have been caused by both the depletion
of macrophages and stimulation with an acute hypoxemia.
In this study, we were unable to define the origin of
the erythroid cells that expressed embryonic globins. Be-
cause some tissue macrophages originate in the yolk sac
and then proliferate in peripheral tissues [45, 46], we
were unable to eliminate the possibility that these cells
were derived from primitive hematopoietic cells and that
these primitive erythroid precursor cells might be reacti-
vated by the elimination of stroma cells and the presence
of hypoxic stress. Further studies will be necessary to
determine the origin of these cells.
New structures were unexpectedly induced in the peri-
toneum and/or omentum of some of the splenectomized
mice that were treated with both NBP and PHZ (Fig. 6).
These were wine-colored structures that resembled hemal
nodes and showed active hematopoiesis. Extramedullaryerythropoiesis is induced in various organs by certain
conditions such as acute anemia, NBP injection, myelo-
fibrosis, and blood cancer [26–28]. The induction of
hemal node-like structures could be caused by insuffi-
cient hematopoiesis in the BM and the liver. Further
study is required to clarify the mechanism that cause
the induction of these newly hematopoietic organs.
The results showing that a relatively large number of
erythroblasts form clusters and nucleated erythrocytes in
the peripheral blood suggest the existence of primitive
erythroid cells in the mice. These cells were large, nu-
cleated erythrocytes. The presence of embryonic or
fetal hemoglobin has been suggested in hematopoietic
progenitors in human peripheral blood, but this does
not explain the expression of these hemoglobin in
hematopoietic sites [47, 48]. Several reports have also
demonstrated the expression of embryonic or fetal glo-
bins in vitro [49, 50]; however, our study has shown for
the first time, the simultaneous expression of embry-
onic and adult globins in erythrocytes in genetically
normal mice. These results contribute to our under-
standing of normal and disease-related hematopoiesis.Conclusions
We established a severely anemic mice model by the
sequential treatment with NBP and PHZ. This model
showed the emergence of nucleated erythrocytes in
peripheral blood and the expressions of embryonic types
of hemoglobin in hematopoietic sites. Our results might
indicate the flexible property of hematopoiesis and the
possibility that yolk sac-derived primitive erythroid cells
may persist into adulthood in mice.Availability of data and materials
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